Efficacy of Ayurvedic “Amalaki Rasayan”for treating residual effects of viralinfection COVID-19

Abstract

Introduction: Amalaki rasayan is a unique formulation of Emblica officinalis, also commonly known as amla.
Amla is a strong antioxidant and rejuvenating fruit, which is potentiated to formulate Amalaki Rasayan. This
study elaborates on the preparation and standardization of the formulation. Its clinical trial in long COVID
has been reported in this article in patients with long COVID having residual symptoms of the viral infection.
Methods: Amalaki Rasayan was formulated and kept immersed in bhasma rashi, i.e., cow dung ash for 4 months
for maturation. A single-arm open-label clinical trial of Amalaki Rasayan was conducted in 15 long-COVID
patients for 30 days, after mild laxative treatment by Haritakyadi Yoga. Results: There was significant
improvement in the WHO well-being score and reduction in symptoms, namely anorexia, fatigue, continuous
headache, joint pain, anxiety, and dyspnea in post-COVID patients after 30 days of administration of Amalaki
Rasayan. Conclusion: After administration of Amalaki Rasayan, the long-term residual effects after viral infection
COVID-19 were significantly reduced and improvement in mood and well-being was noted. No adverse effects
were noted.